Congratulations to ISA Pharmaceuticals, Chief Scientific Officer & Founder, Professor Dr. Kees Melief who was recently awarded two prestigious awards at this year’s 37th Society for Immunotherapy of Cancer Annual Meeting for his outstanding contribution to the field of cancer immunotherapy and his longstanding commitment and achievements that have the potential to significantly improve patient outcomes for the treatment of cancer.
In recognition and celebration of Professor Melief’s pioneering work and dedication to oncology, he was honoured with the ‘2022 Pedro J. Romero Service to the Journal for Immunotherapy of Cancer Award’ and was inducted as a ‘Fellow of the Academy of Immuno-Oncology’ at this year’s Annual Awards.
Professor Melief is a globally recognized immunology expert, specializing in cancer immunotherapy. He is known for his groundbreaking work in devising new cancer therapies. In addition to his role as CSO at ISA Pharmaceuticals, he is Emeritus Professor of Immunology at the Leiden University Medical Center in the Netherlands. He is author of more than 545 peer-reviewed publications, cited over 67.000 times, and inventor on more than 30 patents and patent applications.
Learn more about Professor Melief and his medical guidance within ISA Pharmaceuticals here…